Rocket


Overview
Financials
News + Filings





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dermavant Sciences Ltd

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-19Mar-31-18
   S-1/AS-1/A
Revenues  252.337.4
            Revenue growth  574.5% 
Cost of goods sold  0.00.0
Gross profit  252.337.4
            Gross margin  100.0%100.0%
Selling, general and administrative  273.242.1
Other operating expenses  234.838.1
EBITDA   [+]-255.6-42.7
            EBITDA margin  -101.3%-114.3%
Depreciation and amortization  0.10.0
EBIT   [+]-255.8-42.8
            EBIT margin  -101.4%-114.3%
Other income (expense), net  0.50.3
Pre-tax income  -255.2-42.4
Income taxes  0.10.3
Net income  -255.3-42.7
            Net margin  -101.2%-114.2%
   
Basic EPS   [+]($18.45)($3.45)
Diluted EPS   [+]($18.45)($3.45)
   
Shares outstanding (basic)   [+]13.812.4
Shares outstanding (diluted)   [+]13.812.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy